| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/17/2008 | CN101322758A Method for producing spina date seed extract using complex enzyme |
| 12/17/2008 | CN101322753A Qianzheng plaster |
| 12/17/2008 | CN101322748A Hypericum perforatum total flavones and formulation preparation and quality testing method |
| 12/17/2008 | CN101322736A Medicament composition for preventing and treating cognitive disorder disease |
| 12/17/2008 | CN101322718A Injection for reducing drug dependency and preparation thereof |
| 12/17/2008 | CN101322713A Applications of gastrodine in preparing cysteine proteinase-3 active inhibitor |
| 12/17/2008 | CN101322709A Medicament composition containing aripiprazole and preparation thereof |
| 12/17/2008 | CN101322706A Applications of hexa-gelsemicine in preparing medicament for treating chronic ache |
| 12/17/2008 | CN101322705A Applications of koumine in preparing medicament for treating chronic ache |
| 12/17/2008 | CN101322704A Applications of gelsemine in preparing medicament for treating chronic ache |
| 12/17/2008 | CN101322691A Naloxone hydrochloride nano granule powder injection formulation and preparation thereof |
| 12/17/2008 | CN101322688A Flumazenil oil-in-water emulsion for vein and preparation thereof |
| 12/17/2008 | CN101322608A Chinese medicine pillow |
| 12/17/2008 | CN100443487C N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 12/17/2008 | CN100443480C Tricyclic compound and its preparation and use |
| 12/17/2008 | CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 12/17/2008 | CN100443477C Substituted benzoxazoles and analogues as estrogenic agents |
| 12/17/2008 | CN100443113C Anshenbunao granule and its preparation method |
| 12/17/2008 | CN100443086C New use of ginseng saponin-Re medicine and its preparation method |
| 12/17/2008 | CN100443084C Alprostadil preparation and its making method |
| 12/17/2008 | CN100443083C Use of aconine in medicine manufacture |
| 12/16/2008 | US7465815 Cannabinoid receptor modulator |
| 12/16/2008 | US7465795 Compounds and uses thereof |
| 12/16/2008 | US7465744 Triazole compounds and the therapeutic use thereof |
| 12/16/2008 | US7465741 selective serotonine (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenocptor antagonist activity; To treat anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders including anorexia nervosa and bulimia without being sedative |
| 12/16/2008 | US7465737 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 12/16/2008 | US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 12/16/2008 | US7465733 trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders |
| 12/16/2008 | US7465730 Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds |
| 12/16/2008 | US7465725 e.g. N-{2-[3-(3,4-dimethoxy-phenyl)-propyl]-6-morpholin-4-yl-pyrimidin-4-yl}-N'-(1H-indol-3-ylmethylene)-hydrazine; interleukin-12 antagonist; antiinflammatory, antidiabetic agent; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus |
| 12/16/2008 | US7465718 Ansamycins having improved pharmacological and biological properties |
| 12/16/2008 | US7465582 expression of Nurr1 above basal levels in neural stem cells or neural progenitor cells increases the proportion of the cells which differentiate toward a neural fate |
| 12/16/2008 | US7465548 associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases |
| 12/16/2008 | US7465462 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 12/16/2008 | US7465441 Using interleukins, immunoglobulin fusion; genetic engineering; signaling |
| 12/16/2008 | US7465437 Delivery of anti-migraine compounds through an inhalation route |
| 12/16/2008 | US7465436 Aerosol for delivery of benzotropine, pergolide, amantadine, deprenyl, or ropinerole, formed by vaporizing the drug that is coated on a solid support and condensing the vapor to form particles containing least 10 % by weight of the drug and less than 5 % by weight of degradation products |
| 12/16/2008 | US7465435 Delivery of beta-blockers through an inhalation route |
| 12/16/2008 | CA2399377C New positive allosteric ampa receptor modulators (paarm), processes for preparing them and their use as pharmaceutical compositions |
| 12/16/2008 | CA2395129C Process for producing nanometer particles by fluid bed spray-drying |
| 12/16/2008 | CA2328411C Glucocorticoid receptor antagonists for the treatment of dementia |
| 12/16/2008 | CA2285817C Novel basic derivatives of benz[e]isoindol-1-ones and pyrrolo[3,4-c] quinolin-1-ones with 5-ht3-antagonistic activity, their preparation and their therapeutic use |
| 12/12/2008 | CA2591315A1 Method for treatment of depression and depressive mood disorders |
| 12/11/2008 | WO2008150949A1 HUMANIZED ANTIBODIES TO Aß(20-42) GLOBULOMER AND USES THEREOF |
| 12/11/2008 | WO2008150848A1 Antidepressant heteroaryl derivatives of heterocycle-fused benzodioxans |
| 12/11/2008 | WO2008150525A1 Anti-notch1 nrr antibodies and methods using same |
| 12/11/2008 | WO2008150302A1 Treatment of neurofibromatosis with radicicol and its derivatives |
| 12/11/2008 | WO2008150233A1 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842 |
| 12/11/2008 | WO2008150232A1 Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators - 841 |
| 12/11/2008 | WO2008150217A1 2-amino-5, 5-diaryl-imidazol-4-one analogs for the inhibition of beta-secretase |
| 12/11/2008 | WO2008150001A1 Adipocluster |
| 12/11/2008 | WO2008149980A1 Fibrosis inhibitor |
| 12/11/2008 | WO2008149428A1 Therapeutic agent and preventive agent for autoimmune disease, inflammation and nerve disease |
| 12/11/2008 | WO2008149354A2 Agents for the treatment of inflammatory diseases and methods of using same |
| 12/11/2008 | WO2008149283A1 Composition for supressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect |
| 12/11/2008 | WO2008149152A1 Novel process |
| 12/11/2008 | WO2008148879A2 Use of a substance to improve postoperative outcome after end-to-end reconstruction of peripheral nerves |
| 12/11/2008 | WO2008148860A1 New neuronal viability factor and use thereof |
| 12/11/2008 | WO2008148839A2 Long-acting polymeric prodrugs of exendin |
| 12/11/2008 | WO2008148836A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 12/11/2008 | WO2008148832A1 Compounds which potentiate ampa receptor and uses therof in medicine |
| 12/11/2008 | WO2008148799A1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 12/11/2008 | WO2008148747A2 Pdz domain modulators |
| 12/11/2008 | WO2008148689A1 Prolinamide derivatives as nk3 antagonists |
| 12/11/2008 | WO2008148688A1 Prolinamide-tetrazole derivatives as nk3 receptor antagonists |
| 12/11/2008 | WO2008148303A1 A composition for treating vegetative dystonine syndrome and pharmaceutical preparation and application thereof |
| 12/11/2008 | WO2008130953A3 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands |
| 12/11/2008 | WO2008116665A8 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists |
| 12/11/2008 | WO2008113863A3 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
| 12/11/2008 | WO2008111063A3 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions |
| 12/11/2008 | WO2008099083A3 Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases |
| 12/11/2008 | WO2008087458A3 NEW SIGMA(σ)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION |
| 12/11/2008 | WO2008085074A3 1, 3-dihydroimidazoles for treating cardiovascular disorders |
| 12/11/2008 | WO2008034041A3 Therapeutic combinations |
| 12/11/2008 | WO2008019388A3 Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome |
| 12/11/2008 | WO2008001182A8 Tricyclic heteroaryl compounds as pde10 inhibitors |
| 12/11/2008 | WO2007145571A9 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 12/11/2008 | WO2007145570A9 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 12/11/2008 | WO2007145569A9 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 12/11/2008 | WO2007145568A9 Amino-imidazolones and their use as a medicament for treating cognitive impairment, alzheimer disease, neurodegeneration and dementia |
| 12/11/2008 | WO2007138336A3 Treatment of pain by single chain, polypeptide fusion protein |
| 12/11/2008 | WO2007061661A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/11/2008 | US20080306286 Isolation, Purification and Synthesis of Procyanidin B2 and Uses Thereof |
| 12/11/2008 | US20080306212 Polymer conjugates of mutated neublastin |
| 12/11/2008 | US20080306166 Compositions and Methods For Treatment of Disorders of Protein Aggregation |
| 12/11/2008 | US20080306162 Treatment of Inflammatory Disorders and Pain |
| 12/11/2008 | US20080306161 Use of Axomadol for Treatment of Arthrosis Pain |
| 12/11/2008 | US20080306146 Dosing Regimens for Cox-2 Inhibitor |
| 12/11/2008 | US20080306143 Cathechins for the Treatment of Fibrillogenesis in Alzheimer's Disease, Parkinson's Disease, Systemic AA Amyloidosis, and Other Amyloid Disorders |
| 12/11/2008 | US20080306142 Isolation, purification and synthesis of procyanidin B2 and uses thereof |
| 12/11/2008 | US20080306136 Substituted Ureas and Carbamates |
| 12/11/2008 | US20080306133 Intranasal administration of asenapine and pharmaceutical compositions therefor |
| 12/11/2008 | US20080306131 Progesterone receptor modulator and uses thereof |
| 12/11/2008 | US20080306124 Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands |
| 12/11/2008 | US20080306123 Novel compounds |
| 12/11/2008 | US20080306122 (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide; depression or a mood disorder ; modulation of use-dependent voltage-gated sodium channels |
| 12/11/2008 | US20080306120 Azaindole inhibitors of aurora kinases |
| 12/11/2008 | US20080306115 Midazole-4-Carboxamide Derivatives For Use As Cb1 Modulators |
| 12/11/2008 | US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione |
| 12/11/2008 | US20080306112 Benzimidazolones Which Have Activity at M1 Receptor |